TFF Pharmaceuticals ( (TFFP) ) has provided an announcement.
TFF Pharmaceuticals, Inc. is set to dissolve following its board’s approval of a liquidation plan, pending stockholder consent. Consequently, the company terminated its workforce and ended a patent license agreement with The University of Texas. The board appointed Craig R. Jalbert to oversee the company’s wind-down, leveraging his expertise in managing distressed businesses. The company anticipates one-time charges related to the workforce reduction, highlighting the financial impact of the dissolution process.
For detailed information about TFFP stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Tesla Stock
- ‘Breath of Fresh Air,’ Says Daniel Ives About Rivian Stock
- ‘It’s Not Too Late to Load Up,’ Says Analyst About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
